CWM
ABBV icon

Cordatus Wealth Management’s AbbVie ABBV Stock Holding History

Cordatus Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.13M Buy
16,405
+25
+0.2% +$5.38K 0.91% 32
2026
Q1 		$3.56M Sell
16,380
-225
-1% -$49.9K 0.85% 35
2025
Q4 		$3.79M Buy
16,605
+3
+0% +$683 0.88% 28
2025
Q3 		$3.84M Buy
16,602
+102
+0.6% +$20.8K 0.91% 28
2025
Q2 		$3.06M Sell
16,500
-7
-0% -$1.3K 0.75% 35
2025
Q1 		$3.46M Buy
16,507
+527
+3% +$102K 0.95% 28
2024
Q4 		$2.84M Buy
15,980
+642
+4% +$118K 0.75% 41
2024
Q3 		$3.03M Buy
15,338
+146
+1% +$27.2K 1.09% 25
2024
Q2 		$2.61M Buy
15,192
+2,100
+16% +$348K 0.98% 28
2024
Q1 		$2.38M Buy
13,092
+70
+0.5% +$12.1K 1.73% 18
2023
Q4 		$2.02M Sell
13,022
-1,626
-11% -$237K 1.67% 18
2023
Q3 		$2.18M Sell
14,648
-153
-1% -$22.5K 1.99% 16
2023
Q2 		$1.99M Buy
14,801
+12,938
+694% +$1.9M 0.75% 45
2023
Q1 		$297K Hold
1,863
– – 0.38% 52
2022
Q4 		$301K Buy
+1,863
New +$286K 0.44% 48

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cordatus Wealth Management's ABBV Position: Q2 2026 in Review

Cordatus Wealth Management increased its AbbVie (ABBV) stake by 0.15% in Q2 2026, buying an estimated $5.38K and bringing the position to 16,405 shares worth $4.13M. The position accounts for 0.91% of the portfolio, ranked #32.

Cordatus Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cordatus Wealth Management held 16,405 shares of AbbVie worth $4.13M as of Q2 2026.
  • Cordatus Wealth Management bought 25 AbbVie shares in Q2 2026, an estimated $5.38K.
  • AbbVie made up 0.91% of Cordatus Wealth Management's portfolio in Q2 2026, its #32 holding.
  • Cordatus Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cordatus Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.